naftopidil has been researched along with Liver Dysfunction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, SM; Alstead, EM; Farthing, MJ; Haug, G; Hermann, R; Johnston, A; Molz, KH; Niebch, G; Ruus, P; Turner, P | 1 |
1 trial(s) available for naftopidil and Liver Dysfunction
| Article | Year |
|---|---|
Pharmacokinetics of naftopidil, a novel anti-hypertensive drug, in patients with hepatic dysfunction.
Topics: Administration, Oral; Aged; Antihypertensive Agents; Biological Availability; Female; Half-Life; Humans; Infusions, Intravenous; Liver; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged; Naphthalenes; Piperazines | 1994 |